Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mohammad Bilal Siddiqui"'
Autor:
Michael O. Idowu, Emily Lee, Velimir A. Luketic, Jose A. Hernandez Roman, Arun J. Sanyal, Emily Zhang, Steve Shen, Mohammad Bilal Siddiqui, Robert J. Mintini, Masoud Faridnia, Samarth Patel, Sherry Boyett, Mohammad S. Siddiqui
Publikováno v:
Clin Gastroenterol Hepatol
Nonalcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease,1 is independently associated with increased risk of cardiovascular disease (CVD), which is the leading cause of mortality in patients with NAFLD.2 This is likel
Autor:
Mohammad Bilal Siddiqui, Tamoore Arshad, Susan Wolver, Trevor Reichman, Chandra Bhati, Mohammad S. Siddiqui, Emily Lee, Samarth Patel, Somaya Albhaisi, Carolyn Driscoll
Publikováno v:
Transplantation. 103:2323-2328
BACKGROUND Cardiovascular disease (CVD) is an important cause of morbidity and mortality after liver transplantation (LT). Serum adiponectin levels inversely correlate with CVD-related outcomes, but the relationship between hypoadiponectinemia and CV
Autor:
Samarth Patel, Anchalia Chadrakumaran, Mohammad S. Siddiqui, Susan Wolver, Jose A. Hernandez Roman, Francesco S. Celi, Mohammad Bilal Siddiqui, Chandra Bhati, Masoud Faridnia, Danielle L. Kirkman, Salvatore Carbone, Fei-Pi Lin, Joseph Clinton, John Laurenzo
Publikováno v:
Digestive Diseases and Sciences. 65:639-646
Weight gain after liver transplantation (LT) is a predictor of major morbidity and mortality post-LT; however, there are no data regarding weight loss following LT. The current study evaluates the effectiveness of standard lifestyle intervention in L
Autor:
Samarth Patel, Viviana Rodríguez, Chandra Bhati, Adam Sima, Anchalia Chandrakumaran, Danielle L. Kirkman, John Laurenzano, Joseph Clinton, Masoud Faridnia, Erika Liptrap, Gurukripa N. Kowlgi, Mohammad S. Siddiqui, Mohammad Bilal Siddiqui, Fei-Pi Lin
Publikováno v:
Liver Transpl
Cardiovascular disease (CVD) is a major contributor to longterm mortality after liver transplantation (LT) necessitating aggressive modification of CVD risk. However, it is unclear how coronary artery disease (CAD) and the development of dyslipidemia
Autor:
Taylor Pence, Mohammad S. Siddiqui, Antonio Abbate, Viviana Rodríguez, Chandra Bhati, Trevor Reichman, Fei-Pi Lin, Binu John, Samarth Patel, Adam Sima, Mohammad Bilal Siddiqui
Publikováno v:
Liver Int
BACKGROUND & AIMS Cardiovascular complications are major contributors to mortality at liver transplantation (LT). However, the impact of coronary artery disease (CAD) on these complications is not well-understood as the literature is limited by non-i
Autor:
Mohammad Bilal Siddiqui, Samarth Patel, Robert J. Minniti, Mohammad S. Siddiqui, Jose Hernandez Roman, Adam Sima, Sherry Boyett, Masoud Faridnia, Genta Kakiyama, Michael V. Patrone, Arun J. Sanyal, Anchalia Chandrakumaran, William M. Pandak, Viviana Rodríguez, Chandra Bhati, Emily Zhang, Caroline Walker, Jasmohan S. Bajaj
Publikováno v:
Digestive diseases and sciences. 66(1)
The prevalence of coronary artery disease (CAD) is high among patients with cirrhosis; however, the impact of it on cardiovascular disease (CVD) is not known. The aim of the current study was to evaluate CVD events in patients with cirrhosis and impa
Publikováno v:
Hepatology (Baltimore, Md.)References. 71(1)
Autor:
Samarth Patel, Somaya Albhaisi, Richard K. Sterling, Mohammad Bilal Siddiqui, Mohammad S. Siddiqui, Emily Lee, Arun J. Sanyal, Trevor Reichman, R. Todd Stravitz, Carolyn Driscoll, Tamoore Arshad, Chandra Bhati
Publikováno v:
Hepatology
Cardiovascular disease (CVD) is an important cause of morbidity and mortality after liver transplantation (LT). Although LT is associated with dyslipidemia, particularly atherogenic lipoprotein subparticles, the impact of these subparticles on CVD-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26dc017ac5383a3c132818ba3b8f418
https://europepmc.org/articles/PMC7018439/
https://europepmc.org/articles/PMC7018439/
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 18(8)
Autor:
M. Shadab Siddiqui, Carolyn Driscoll, Mary E. Rinella, Richard K. Sterling, Erika Liptrap, Samarth Patel, Trevor Reichman, Kenyada Williams, Chandra Bhati, Mohammad Bilal Siddiqui
Publikováno v:
Transplant Proc
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are used to monitor liver transplant recipients (LTR) but the reference range and context of its use is not well defined. We aimed to determine the healthy ranges in LTR without chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04e7a661a013e5cfec0c3132370956b
https://europepmc.org/articles/PMC7050287/
https://europepmc.org/articles/PMC7050287/